Independent Research
IONS Analysis
2 pieces of research on Ionis Pharmaceuticals, Inc.. We find the signal management buried in the earnings call.
2signal analyses
0news briefs
latest: Sep 30, 2026
Signal Analysis (2)
Analysis
Ionis CSO Sells $1.7M as Stock Falls to $44 vs $84 Target
Three Ionis executives, including the Chief Scientific Officer, sold $2.6 million in shares at $83-$85 in July. The stock has since fallen 46% to $44.65, despit…
Read analysis →Analysis
Ionis Insiders Sold at $85, Then Bought at $52
Goldman Sachs raised its Ionis Pharmaceuticals price target today, lifting shares 4% in after-hours trading, yet the stock sits roughly 28% below the $79 to $85…
Read analysis →